Healthcare Realty Trust (NYSE:HR) Issues FY25 Earnings Guidance

Healthcare Realty Trust (NYSE:HR) updated its FY25 earnings guidance on Wednesday. The company provided earnings per share guidance of $1.56 to $1.60 for the period, compared to the consensus earnings per share estimate of $1.59. Healthcare Realty Trust also updated its FY 2025 guidance to 1.560-1.600 EPS.

Analyst Upgrades and Downgrades

HR has been the topic of several analyst reports. Wedbush downgraded shares of Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and cut their price target for the company from $18.00 to $16.00 in a report on Thursday, January 2nd. JPMorgan Chase & Co. cut shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price target for the company. in a report on Friday, December 20th. Finally, Jefferies Financial Group lowered shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and cut their price objective for the stock from $19.00 to $17.00 in a research note on Thursday, January 2nd. Two research analysts have rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $17.00.

Healthcare Realty Trust Trading Down 1.3 %

HR stock traded down $0.22 on Wednesday, hitting $16.77. The company’s stock had a trading volume of 3,389,697 shares, compared to its average volume of 2,402,787. The firm has a 50 day moving average of $16.69 and a two-hundred day moving average of $17.42. Healthcare Realty Trust has a 1 year low of $12.77 and a 1 year high of $18.90. The stock has a market cap of $5.94 billion, a price-to-earnings ratio of -10.61 and a beta of 0.94.

Healthcare Realty Trust (NYSE:HR) last announced its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.01. The company had revenue of $309.77 million for the quarter, compared to analysts’ expectations of $303.81 million. Healthcare Realty Trust had a negative net margin of 45.63% and a negative return on equity of 9.42%. Healthcare Realty Trust’s revenue was down 6.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.39 EPS. As a group, equities analysts forecast that Healthcare Realty Trust will post 1.55 EPS for the current fiscal year.

Insider Transactions at Healthcare Realty Trust

In related news, Director Thomas N. Bohjalian purchased 7,750 shares of the stock in a transaction dated Friday, November 22nd. The shares were acquired at an average cost of $17.39 per share, with a total value of $134,772.50. Following the purchase, the director now directly owns 50,002 shares in the company, valued at $869,534.78. This trade represents a 18.34 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Robert E. Hull sold 10,000 shares of the stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $17.48, for a total transaction of $174,800.00. Following the completion of the sale, the chief operating officer now directly owns 171,400 shares in the company, valued at approximately $2,996,072. The trade was a 5.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have purchased a total of 18,750 shares of company stock valued at $323,723 in the last ninety days. 0.56% of the stock is currently owned by company insiders.

About Healthcare Realty Trust

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.